IR Events

38th Annual J.P. Morgan Healthcare Conference (4:00pm-4:55pm PST on January 14, 2020)

Presentation
J.P. Morgan Healthcare Conference Presentation
Click to download

R&D Day and Plasma-Derived Therapies Day in Tokyo (11:00am-5:00pm JST on November 21, 2019)

Webcast

Plasma-Derived Therapies

  • Plasma-Derived Therapies Overview 
    Julie Kim, President, Plasma-Derived Therapies Business Unit
  • Plasma-Derived Therapies R&D 
    Christopher Morabito, Head, R&D, Plasma-Derived Therapies
    Click to Download 

R&D Day

All slides
Click to Download 

  • Takeda: A Global Values-Based, R&D-Driven Biopharmaceutical Leader 
    Christophe Weber, President & CEO
    Click to Download 
  • Translating Science into Highly Innovative, Life-changing Medicines 
    Andy Plump, President, R&D
    Click to Download 
  • Oncology and Cell Therapies with Spotlight on CAR-NK 
    Chris Arendt, Head, Oncology Drug Discovery Unit
    Click to Download 
  • Spotlight on Oncology Opportunities TAK-788 
    Rachael Brake, Global Program Leader, Oncology
    Click to Download 
  • Spotlight on Oncology Opportunities Pevonedistat 
    Phil Rowlands, Head, Oncology Therapeutic Area Unit
    Click to Download 
  • Rare Diseases & Gene Therapy 
    Dan Curran, Head, Rare Disease Therapeutic Area Unit
    Click to Download 
  • Spotlight on Orexin2R agonists 
    Deborah Hartman, Global Program Leader, Neuroscience
    Click to Download 
  • Therapeutic Area Focus in GI with Spotlight on Celiac Disease 
    Asit Parikh, Head, GI Therapeutic Area Unit
    Click to Download 

Takeda R&D Pipeline Narrative
Click to Download

Plasma-Derived Therapies Day in Covington, Georgia (11:15am-3:45pm EST on November 15, 2019)

Webcast

All slides
Click to Download 

  • Plasma-Derived Therapies Overview 
    Julie Kim, President, Plasma-Derived Therapies Business Unit

  • Plasma-Derived Therapies R&D 
    Christopher Morabito, Head, R&D, Plasma-Derived Therapies

  • Covington Site Introduction 
    Carlos Soto, Covington Site Head

R&D Day in New York (12:30pm-4:00pm EST on November 14, 2019)

Webcast

All slides
Click to Download

Welcome and Opening Remarks
Sheelagh Cawley-Knopf, Head, R&D Global Portfolio Strategy

  • Takeda: A Global Values-Based, R&D-Driven Biopharmaceutical Leader
    Christophe Weber, President & CEO
    Click to Download 
  • Translating Science into Highly Innovative, Life-changing Medicines
    Andy Plump, President, R&D
    Click to Download 
  • Oncology and Cell Therapies with Spotlight on CAR-NK
    Chris Arendt, Head, Oncology Drug Discovery Unit
    Click to Download
  • Spotlight on Oncology Opportunities TAK-788
    Rachael Brake, Global Program Leader, Oncology
    Click to Download 
  • Spotlight on Oncology Opportunities Pevonedistat
    Phil Rowlands, Head, Oncology Therapeutic Area Unit
    Click to Download 
  • Rare Diseases & Gene Therapy
    Dan Curran, Head, Rare Disease Therapeutic Area Unit
    Click to Download
  • Spotlight on Orexin2R agonists
    Deborah Hartman, Global Program Leader, Neuroscience
    Click to Download 
  • Therapeutic Area Focus in GI with Spotlight on Celiac Disease
    Asit Parikh, Head, GI Therapeutic Area Unit
    Click to Download

Takeda R&D Pipeline Narrative
Click to Download

IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit (Held on October 10, 2019)

Morgan Stanley Healthcare Conference (Held on September 10, 2019 ET)

This event was closed.

IR Seminar “Plasma-Derived Therapies Business” (Held on July 12, 2019)